In order to facilitate the reading of this Universal Registration Document, the following table provides the page references of the main information required by Annex 1 of European delegated regulation No. 2019/980, completing the European regulation No. 2017/1129.
Schedule based on annex 1 European delegated regulation No. 2019/980 | Pages |
---|---|
1. Persons responsible | 1. Persons responsiblePages
|
1.1. Name and function of the persons responsible | 1.1. Name and function of the persons responsible Pages388 |
1.2. Declaration of the persons responsible | 1.2. Declaration of the persons responsible Pages388 |
1.3. Expert statements | 1.3. Expert statements PagesN/A |
1.4. Information from third parties | 1.4. Information from third parties Pages20 |
1.5. Declaration without approval of the competent authority | 1.5. Declaration without approval of the competent authority Pages1 |
2. Statutory Auditors | 2. Statutory AuditorsPages 388 |
3. Risk factors | 3. Risk factorsPages 141-150 |
4. Information about the issuer | 4. Information about the issuerPages 346-347 |
4.1. Corporate name | 4.1. Corporate name Pages346 |
4.2. Place and number of incorporation and ID of legal entity | 4.2. Place and number of incorporation and ID of legal entity Pages346 |
4.3. Creation date and duration | 4.3. Creation date and duration Pages346 |
4.4. Headquarters, legal form, applicable law, country of origin, address and phone number of headquarters, and website | 4.4. Headquarters, legal form, applicable law, country of origin, address and phone number of headquarters, and website Pages346, fourth cover |
5. Business overview | 5. Business overviewPages
|
5.1. Principal activities | 5.1. Principal activities Pages14-18 |
5.2. Principal markets | 5.2. Principal markets Pages18-19, 20 |
5.3. Important factors | 5.3. Important factors Pages43-45, 333, 364 |
5.4. Strategy and objectives | 5.4. Strategy and objectives Pages2-3, 14-18, 47-49,156 |
5.5. Extent to which the issuer is dependent on patents or licenses, industrial, commercial or financial contracts or new manufacturing processes | 5.5. Extent to which the issuer is dependent on patents or licenses, industrial, commercial or financial contracts or new manufacturing processes Pages27-30, 149 |
5.6. Basis for any statements made by the issuer regarding its competitive position | 5.6. Basis for any statements made by the issuer regarding its competitive position Pages20 |
5.7. Investing activities | 5.7. Investing activities Pages
|
5.7.1. Important investments completed | 5.7.1. Important investments completed Pages35, 45 |
5.7.2. Important investments being completed or contemplated | 5.7.2. Important investments being completed or contemplated Pages308 |
5.7.3. Participation in joint ventures and undertakings | 5.7.3. Participation in joint ventures and undertakings Pages310-312, 334-337 |
5.7.4. Environmental issues that may affect the issuer’s utilisation of the tangible fixed assets | 5.7.4. Environmental issues that may affect the issuer’s utilisation of the tangible fixed assets Pages47-49, 147-148,161, 162 - 207,307-308 |
6. Organisational structure | 6. Organisational structurePages
|
6.1. Brief description of the Group | 6.1. Brief description of the Group Pages6-19, 50 |
6.2. List of the significant subsidiaries | 6.2. List of the significant subsidiaries Pages310-312, 334-337 |
7. Operating and financial review | 7. Operating and financial reviewPages
|
7.1. Financial condition | 7.1. Financial condition Pages
|
7.1.1. Review of the development and performance of the issuer’s business and its financial position in historical interim periods | 7.1.1. Review of the development and performance of the issuer’s business and its financial position in historical interim periods Pages16-19, 21-23, 36-45, 254-259, 318-321 |
7.1.2. The issuer’s future development and its activities in the field of research and development | 7.1.2. The issuer’s future development and its activities in the field of research and development Pages26-30, 45 |
7.2. Operating profit | 7.2. Operating profit Pages39-42, 254, 318 |
8. Capital resources | 8. Capital resourcesPages
|
8.1. Information concerning the issuer’s capital resources | 8.1. Information concerning the issuer’s capital resources Pages256-259, 319-320 |
8.2. Sources and amounts of cash flows | 8.2. Sources and amounts of cash flows Pages259, 321 |
8.3. Information on the borrowing requirements and funding structure | 8.3. Information on the borrowing requirements and funding structure Pages22, 291-293, 330 |
8.4. Restrictions on the use of capital resources that have materially affected or could materially affect the Company’s operations | 8.4. Restrictions on the use of capital resources that have materially affected or could materially affect the Company’s operations Pages291, 326 |
8.5. Anticipated sources of funds needed to fulfil investments on which the management bodies have already made firm commitments and planned material tangible fixed assets | 8.5. Anticipated sources of funds needed to fulfil investments on which the management bodies have already made firm commitments and planned material tangible fixed assets Pages42 |
9. Regulatory environment | 9. Regulatory environmentPages 19, 28, 32, 143, 148-149, 160-161 |
10. Trend information | 10. Trend informationPages
|
10.1. Main trends and change in the financial performance since year end | 10.1. Main trends and change in the financial performance since year end Pages45 |
10.2. Event likely to impact perspectives | 10.2. Event likely to impact perspectives Pages45 |
11. Profit forecasts or estimates | 11. Profit forecasts or estimatesPages N/A |
12. Board of Directors and General Management | 12. Board of Directors and General ManagementPages
|
12.1. Information about the Board of Directors and the General Management | 12.1. Information about the Board of Directors and the General Management Pages9-13, 54-56, 63-70 |
12.2. Conflicts of interests | 12.2. Conflicts of interests Pages55, 62 |
13. Remuneration and benefits | 13. Remuneration and benefitsPages
|
13.1. Amount of remuneration paid and benefits in kind | 13.1. Amount of remuneration paid and benefits in kind Pages102-109, 373-376 |
13.2. Amount set aside or accrued to provide pension, retirement or similar benefits | 13.2. Amount set aside or accrued to provide pension, retirement or similar benefits Pages273-276 |